Evidence-Based Medicine Guidelines
Antiviral therapy for recurrent liver graft infection with hepatitis C virus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antiviral Therapy for Recurrent Liver Graft Infection With Hepatitis C Virus." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454681/all/Antiviral_therapy_for_recurrent_liver_graft_infection_with_hepatitis_C_virus.
Antiviral therapy for recurrent liver graft infection with hepatitis C virus. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454681/all/Antiviral_therapy_for_recurrent_liver_graft_infection_with_hepatitis_C_virus. Accessed October 10, 2024.
Antiviral therapy for recurrent liver graft infection with hepatitis C virus. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454681/all/Antiviral_therapy_for_recurrent_liver_graft_infection_with_hepatitis_C_virus
Antiviral Therapy for Recurrent Liver Graft Infection With Hepatitis C Virus [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454681/all/Antiviral_therapy_for_recurrent_liver_graft_infection_with_hepatitis_C_virus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiviral therapy for recurrent liver graft infection with hepatitis C virus
ID - 454681
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454681/all/Antiviral_therapy_for_recurrent_liver_graft_infection_with_hepatitis_C_virus
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
